Back to Search
CHARLES STURGEON, MD
MD
Internal Medicine Physician
NPI: 1699762807Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G50185(CA)
Research & Publications (20)
Neuromonitoring in thyroid surgery: attitudes, usage patterns, and predictors of use among endocrine surgeons.
PMID 18758849·World J Surg·2009
8-other
Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin.
PMID 19541864·Clin Chem·2009
4-observational
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.
PMID 18325912·Ann Oncol·2008
3-trial
Abrogation of ionizing radiation-induced G2 checkpoint and inhibition of nuclear export by Cryptocarya pyrones.
PMID 17440726·Cancer Chemother Pharmacol·2008
8-other
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
PMID 19042984·Clin Chem·2008
6-review
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
PMID 18606634·Clin Chem·2008
6-review
Improving the comparability of immunoassays for prostate-specific antigen (PSA): progress and problems.
PMID 17408608·Clin Chim Acta·2007
6-review
G2 checkpoint kinase inhibitors exert their radiosensitizing effects prior to the G2/M transition.
PMID 17351346·Cell Cycle·2007
4-observational
Standardization of FSH, LH and hCG--current position and future prospects.
PMID 17113221·Mol Cell Endocrinol·2007
6-review
Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage.
PMID 16648558·Mol Cancer Ther·2006
7-preclinical
Identification and treatment of aggressive thyroid cancers. Part 2: risk assessment and treatment.
PMID 16683416·Oncology (Williston Park)·2006
6-review
Identification and treatment of aggressive thyroid cancers. Part 1: subtypes.
PMID 16629257·Oncology (Williston Park)·2006
6-review
Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
PMID 16500246·J Am Coll Surg·2006
4-observational
Modulation of the G2 cell cycle checkpoint by sesquiterpene lactones psilostachyins A and C isolated from the common ragweed Ambrosia artemisiifolia.
PMID 16254826·Planta Med·2005
8-other
Laparoscopic surgery for melanoma metastases to the adrenal gland.
PMID 15485317·Expert Rev Anticancer Ther·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 265 POSADA LN, SUITE B
TEMPLETON, CA 93465 - Phone
- (805) 434-0900
Quick Facts
- NPI
- 1699762807
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile